Last week, Swiss agribusiness giant Syngenta AG turned down competitor Monsanto Co.'s bid to acquire its business, preventing, for the time being, a merger between two of the world's six largest biotech companies. According to Politico's “Morning Agriculture,” Monsanto sparked curiosity before the deal was rejected when it "released a white paper written by leading antitrust lawyers on how the deal would not fall afoul of antitrust regulations." Craig Coleman, Faegre Baker Daniels partner, said it was unusual for a company to make such a document public, and that it "likely speaks to the recognition that the deal was going to be subject to a high level of scrutiny by the antitrust agencies."
